Susquehanna International Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.3K Buy
23,800
+13,700
+136% +$31.5K ﹤0.01% 12619
2025
Q4
$28.3K Sell
10,100
-113,600
-92% -$406K ﹤0.01% 11889
2025
Q3
$594K Buy
123,700
+88,900
+255% +$566K ﹤0.01% 8578
2025
Q2
$317K Sell
34,800
-19,800
-36% -$146K ﹤0.01% 10214
2025
Q1
$493K Buy
+54,600
New +$576K ﹤0.01% 8935
2024
Q4
Sell
-15,900
Closed -$249K 12921
2024
Q3
$249K Sell
15,900
-2,300
-13% -$34.8K ﹤0.01% 10014
2024
Q2
$246K Sell
18,200
-4,700
-21% -$96.2K ﹤0.01% 9893
2024
Q1
$635K Sell
22,900
-21,000
-48% -$466K ﹤0.01% 7940
2023
Q4
$846K Sell
43,900
-16,200
-27% -$293K ﹤0.01% 7391
2023
Q3
$971K Buy
60,100
+27,000
+82% +$479K ﹤0.01% 6689
2023
Q2
$630K Sell
33,100
-8,500
-20% -$152K ﹤0.01% 7767
2023
Q1
$605K Buy
41,600
+10,000
+32% +$179K ﹤0.01% 8094
2022
Q4
$617K Buy
31,600
+18,900
+149% +$369K ﹤0.01% 7317
2022
Q3
$306K Sell
12,700
-20,100
-61% -$619K ﹤0.01% 9744
2022
Q2
$1.03M Sell
32,800
-17,900
-35% -$648K ﹤0.01% 6469
2022
Q1
$2.23M Sell
50,700
-71,700
-59% -$3.08M ﹤0.01% 5228
2021
Q4
$5.32M Sell
122,400
-139,700
-53% -$5.48M ﹤0.01% 3630
2021
Q3
$8.2M Buy
262,100
+128,700
+96% +$5.07M ﹤0.01% 3164
2021
Q2
$5.65M Sell
133,400
-263,400
-66% -$10.2M ﹤0.01% 3823
2021
Q1
$14.9M Buy
396,800
+263,600
+198% +$8.24M ﹤0.01% 2242
2020
Q4
$3.6M Sell
133,200
-172,600
-56% -$4.44M ﹤0.01% 3993
2020
Q3
$7.68M Buy
305,800
+227,200
+289% +$3.31M ﹤0.01% 2518
2020
Q2
$599K Buy
78,600
+23,800
+43% +$174K ﹤0.01% 6991
2020
Q1
$501K Sell
54,800
-179,700
-77% -$1.08M ﹤0.01% 6930
2019
Q4
$1.21M Sell
234,500
-300
-0.1% -$1.93K ﹤0.01% 5149
2019
Q3
$1.36M Buy
234,800
+213,700
+1,013% +$958K ﹤0.01% 5032
2019
Q2
$68K Sell
21,100
-68,700
-77% -$234K ﹤0.01% 9756
2019
Q1
$368K Buy
89,800
+43,500
+94% +$275K ﹤0.01% 6852
2018
Q4
$293K Sell
46,300
-162,100
-78% -$1.68M ﹤0.01% 7044
2018
Q3
$3.44M Buy
208,400
+81,400
+64% +$1.38M ﹤0.01% 3167
2018
Q2
$2.12M Sell
127,000
-33,400
-21% -$541K ﹤0.01% 3914
2018
Q1
$2.49M Buy
160,400
+40,200
+33% +$717K ﹤0.01% 3525
2017
Q4
$2.27M Buy
120,200
+102,400
+575% +$2.27M ﹤0.01% 3685
2017
Q3
$520K Buy
+17,800
New +$526K ﹤0.01% 6440
2017
Q2
Sell
-9,500
Closed -$329K 9627
2017
Q1
$329K Sell
9,500
-13,800
-59% -$493K ﹤0.01% 7189
2016
Q4
$822K Sell
23,300
-25,600
-52% -$865K ﹤0.01% 5942
2016
Q3
$1.7M Buy
48,900
+30,800
+170% +$1.08M ﹤0.01% 3835
2016
Q2
$677K Buy
18,100
+9,500
+110% +$357K ﹤0.01% 5589
2016
Q1
$348K Buy
+8,600
New +$320K ﹤0.01% 7025
2014
Q3
Sell
-5,900
Closed -$200K 9788
2014
Q2
$200K Buy
+5,900
New +$202K ﹤0.01% 9072

Other funds holding ACH

Susquehanna International Group's ACH Position: Q1 2026 in Review

Susquehanna International Group increased its Accendra Health (ACH) stake by 902% in Q1 2026, buying an estimated $747K and bringing the position to 360,210 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #8411.

Susquehanna International Group first reported a position in ACH in Q3 2013 and has held it in 45 quarters since. The position peaked at $5.53M in Q4 2016. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Susquehanna International Group held 360,210 shares of Accendra Health worth $821K as of Q1 2026.
  • Susquehanna International Group bought 324,270 Accendra Health shares in Q1 2026, an estimated $747K.
  • Accendra Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8411 holding.
  • Susquehanna International Group first reported a position in Accendra Health in Q3 2013 and has held it in 45 quarters since.
  • Susquehanna International Group's Accendra Health position peaked at $5.53M in Q4 2016.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.